Clinical Trials on Polycystic Kidney Diseases in Austria

Total 17278 results

Vienna General Hospital

Completed

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Peripheral Vascular Diseases | Intermittent Claudication | Angioplasty

Austria
Uptake Medical Corp

Completed

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (BTVA)

Chronic Obstructive Pulmonary Disease | Emphysema

Germany, Ireland, Australia, Austria
Medical University of Vienna

Completed

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

Coronary Artery Disease | Ischemic Heart Disease | Heavy Metal Toxicity

Austria
Medical University of Vienna

Completed

Endothelin-Receptor Blockade in Coronary Heart Disease

Vascular Resistance | Coronary Vessels | Endothelins

Austria
Amgen

Terminated

Pediatric Chronic Kidney Disease Safety and Efficacy

Hyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney Disease

United States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
Bayer

Completed

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone (ARTS-HF)

Heart Failure

France, Taiwan, United States, Turkey, Spain, Greece, Portugal, Germany, Canada, Austria, Czechia, Denmark, Israel, Korea, Republic of, Poland, South Africa, Sweden, Bulgaria, Italy, Finland, Hungary, Lithuania, Netherlands, Australia, ...
Medical University of Vienna
University of California, San Diego

Unknown

Calibrating Cardiac Output Measurement of Electrical Cardiometry With Transthoracic Echocardiography (EC vs TTE)

Coronary Artery Disease

Austria
Paracelsus Medical University

Completed

Different Endurance Training Protocols in Cardiac Rehabilitation

Coronary Artery Disease

Austria
Medical University of Vienna

Unknown

Fluid Status in Valvular Heart Disease

Fluid Overload | Cardiovascular Risk Factor | Valvular Heart Disease

Austria
Pharmacosmos A/S

Completed

Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

Inflammatory Bowel Disease | Anaemia

Austria, Hungary
Medical University of Vienna

Recruiting

Cold-induced Brown Fat Activation and Hepatic Steatosis

Non-Alcoholic Fatty Liver Disease

Austria
ReFlow Medical, Inc.

Completed

A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB (DEEPER LIMUS)

Peripheral Arterial Disease | Critical Limb Ischemia

Austria
Paracelsus Medical University

Recruiting

Scatter Radiation Exposure During Coronary Procedures - The Occupational SCAtter Radiation Registry (OSCAR)

Coronary Artery Disease

Austria
Otto Wagner Hospital

Completed

Effects of Dynamic Hyperinflation on the Left-ventricular Diastolic Function in Healthy Male Subjects

Pulmonary Disease, Chronic Obstructive

Austria
Paracelsus Medical University

Completed

Different Endurance Training Protocols in Cardiac Patients

Coronary Artery Disease

Austria
Ipsen

Active, not recruiting

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Neuroendocrine Tumors

Austria, Denmark, Switzerland, Australia, United Kingdom, France
Kepler University Hospital
Krankenhaus Barmherzige Schwestern Linz; Elisabethinen Hospital

Recruiting

Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis (DATE)

Diverticulitis of Sigmoid

Germany, Austria
Boehringer Ingelheim

Recruiting

A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

Kidney Disease, Chronic

United States, Belgium, Australia, Spain, Germany, France, Italy, New Zealand, United Kingdom, China, Ireland
Amgen

Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Hyperparathyroidism, Secondary

United States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
Medical University of Vienna
Medical Scientific Fund of the Mayor of Vienna; Austrian Heart Funds

Completed

Interval Training in Cardiac Rehabilitation

Coronary Artery Disease | Atherosclerosis

Austria
Affiris AG

Completed

Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02

Alzheimer's Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Medical University of Vienna

Unknown

Exercise Training Versus Best Medical Treatment Only in Peripheral Artery Disease

Peripheral Artery Disease

Austria
Medical University of Vienna

Unknown

Antibiotic Concentration in Internal Mammary Graft Preparation

Coronary Heart Disease | Surgical Wound Infection

Austria
Storz Medical AG

Completed

Brain Stimulation for Patients With Parkinson Disease

Parkinson Disease

Austria
Medical University of Vienna
University of Vienna; University Hospital Schleswig-Holstein

Completed

Sport Climbing With Parkinson's Disease

Parkinson Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

Parkinson's Disease

Austria
Medical University of Vienna

Completed

Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy (ENDOvsTIPS)

Cirrhosis | Gastrointestinal Hemorrhage | Encephalopathy | Variceal Bleeding

Austria
CSL Behring

Active, not recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

End Stage Kidney Disease | Atherosclerotic Cardiovascular Disease

United States, Australia, Belgium, Canada, Germany
AUVA Trauma Center Meidling

Unknown

Extracorporeal Shockwave Therapy (ESWT) to Improve Function in Chronic ASIA-A Patients

Spinal Cord Injuries

Austria
Prim PD Dr Afshin Assadian
Wilhelminenspital Vienna

Unknown

The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation (ILOFLOW)

Arteriosclerosis | Diabetes | Peripheral Arterial Occlusive Disease | Neuropathy

Austria
Storz Medical AG
Medical University of Vienna

Completed

Brain Stimulation for Neurological Patients

Alzheimer Disease

Austria
Ever Neuro Pharma GmbH

Withdrawn

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) (DAT)

Alzheimer Disease

Austria
Affiris AG

Completed

Safety and Tolerability of AFFITOPE AD03 (MimoVax)

Alzheimer's Disease

Austria
Affiris AG

Completed

Long-term Safety and Tolerability of AFFITOPE AD02

Alzheimer's Disease

Austria
reMYND
NeuroScios GmbH

Completed

A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127

Alzheimer Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Affiris AG

Completed

Long-term Safety and Tolerability of AFFITOPE AD01

Alzheimer's Disease

Austria
Affiris AG

Completed

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

Parkinson's Disease

Austria
Affiris AG

Completed

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)

Parkinson's Disease

Austria
Affiris AG

Completed

AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A

Parkinson's Disease

Austria
Medical University of Vienna

Completed

Effect of Levodopa on Human Multifocal Electroretinogram

Retinal Diseases

Austria
Medical University of Vienna
State Government of Vienna, Austria (Medizinisch-Wissenschaftlicher Fonds...

Completed

Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.

Non-alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

Austria
AbbVie (prior sponsor, Abbott)
Massachusetts General Hospital

Completed

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 (PRIMO)

Chronic Kidney Disease | Left Ventricular Hypertrophy

United States, Australia, Czech Republic, Germany, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Wide-field Retinal Imaging

Retinal Disease

Austria
Merck Sharp & Dohme LLC

Active, not recruiting

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

Kidney Failure, Chronic | End-Stage Renal Disease | End-Stage Kidney Disease

United States, Argentina, Australia, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Italy, Portugal, Puerto Rico, Romania, Russian Federation, Sweden
Medical University of Vienna

Completed

Endostatin Serum Levels During Bicycle Stress Test

Smoking | Cardiac Diseases

Austria
Medical University of Vienna

Unknown

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Coronary Artery Disease | Aorto-coronary Bypass Grafting

Austria
Austrian Hernia Study Group

Terminated

Randomized Controlled Prospective Multicenter Study Primary Onlay- Mesh After Elective Median Laparotomy in Patients With BMI ≥ 27

Obesity | Incisional Hernia

Austria
Paracelsus Medical University

Completed

Outpatient Cardiac Rehabilitation in Austria

Heart Disease

Austria

Clinical Trials on Polycystic Kidney Diseases in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations